Pharmacology and the Treatment of Complicated Skin and Skin-Structure Infections

被引：19
|
作者：
Chambers, Henry F. [1 ,2 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] San Francisco Gen Hosp, Div Infect Dis, San Francisco, CA 94110 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 370卷 / 23期
关键词：
D O I：
10.1056/NEJMe1405078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2238 / 2239
页数：2
相关论文
共 50 条
  • [41] Initial Treatment Failure in Patients with Complicated Skin and Skin Structure Infections
    Berger, Ariel
    Oster, Gerry
    Edelsberg, John
    Huang, Xingyue
    Weber, David J.
    SURGICAL INFECTIONS, 2013, 14 (03) : 304 - 312
  • [42] Emerging Treatment Options for Complicated Skin and Skin Structure Infections: Oritavancin
    Townsend, Mary L.
    Wilson, Dustin
    Pound, Melanie
    Drew, Richard
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 25 - 35
  • [43] Pharmacodynamic Profiling of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections
    Kimko, Holly
    Xu, Xu
    Nandy, Partha
    Samtani, Mahesh N.
    Strauss, Richard S.
    Bagchi, Partha
    Noel, Gary J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3371 - 3374
  • [44] Concerns about "Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study"
    Lustberg, Mark E.
    Schlesinger, Larry S.
    Mangino, Julie E.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (02) : 313 - 313
  • [45] Outcomes and management costs in patients hospitalized for skin and skin-structure infections
    Itani, Kamal M. F.
    Merchant, Sanjay
    Lin, Swu-Jane
    Akhras, Kasem
    Alandete, Juan Carlos
    Hatoum, Hind T.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2011, 39 (01) : 42 - 49
  • [46] Antimicrobial Agents for Complicated Skin and Skin-Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo-Controlled Trials
    Spellberg, Brad
    Talbot, George H.
    Boucher, Helen W.
    Bradley, John S.
    Gilbert, David
    Scheld, W. Michael
    Edwards, John, Jr.
    Bartlett, John G.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (03) : 383 - 391
  • [47] A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections
    Noel, Gary J.
    Bush, Karen
    Bagchi, Partha
    Ianus, Juliana
    Strauss, Richard S.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (05) : 647 - 655
  • [48] In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections
    Bradford, PA
    Weaver-Sands, DT
    Petersen, PJ
    CLINICAL INFECTIOUS DISEASES, 2005, 41 : S315 - S332
  • [49] Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors
    Zilberberg, Marya D.
    Shorr, Andrew F.
    Micek, Scott T.
    Hoban, Alex P.
    Pham, Victor
    Doherty, Joshua A.
    Ramsey, Andrew M.
    Kollef, Marin H.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (12): : 1203 - 1210
  • [50] A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
    O'Riordan, William
    Mehra, Purvi
    Manos, Paul
    Kingsley, Jeff
    Lawrence, Laura
    Cammarata, Sue
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 30 : 67 - 73
12345